Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noemí Reguart

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Targeted Oncology|October 5, 2018
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)Alejandro Ruiz-Patiño, Christian David Castro, Luisa María Ricaurte, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2025
Corrigendum to "Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)" [Lung Cancer 206 (2025) 108677]Noemí Reguart, Laura Sampietro-Colom, Òscar Juan-Vidal, et al.
Molecular Oncology|May 27, 2023
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniquesAna Giménez-Capitán, Estela Sánchez-Herrero, Lucía Robado de Lope, et al.
Clinical Lung Cancer|March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion RecurrenceFrancisco Javier Muñoz-Carrillo, Roxana Maribel Reyes, David Pesántez, et al.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohortDavid Vicente-Baz, Alfredo Paredes, Teresa Morán, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2020
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)Rosario Garcia-Campelo, Oscar Arrieta, Bartomeu Massuti, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Clinical Chemistry|January 13, 2021
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based PlatformAna Giménez-Capitán, Jillian Bracht, Juan José García, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Targeted Oncology|October 5, 2018
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)Alejandro Ruiz-Patiño, Christian David Castro, Luisa María Ricaurte, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2025
Corrigendum to "Characterization and economic burden of KRASG12C-mutant lung cancer in real-world Spanish practice: a retrospective observational study (SILK study)" [Lung Cancer 206 (2025) 108677]Noemí Reguart, Laura Sampietro-Colom, Òscar Juan-Vidal, et al.
Molecular Oncology|May 27, 2023
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniquesAna Giménez-Capitán, Estela Sánchez-Herrero, Lucía Robado de Lope, et al.
Clinical Lung Cancer|March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion RecurrenceFrancisco Javier Muñoz-Carrillo, Roxana Maribel Reyes, David Pesántez, et al.
Cancer Research|November 8, 2019
Epigenetic <i>SMAD3</i> Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell CarcinomaRafael Ikemori, Marta Gabasa, Paula Duch, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohortDavid Vicente-Baz, Alfredo Paredes, Teresa Morán, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2020
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL)Rosario Garcia-Campelo, Oscar Arrieta, Bartomeu Massuti, et al.
Plos One|September 24, 2014
Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistryEsther Conde, Ana Suárez-Gauthier, Amparo Benito, et al.
Clinical Chemistry|January 13, 2021
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based PlatformAna Giménez-Capitán, Jillian Bracht, Juan José García, et al.
Pageof 8